Viral Vector Vaccines Market, By Disease (Infectious Diseases, Cancer, and Genetic Disorders), By Type, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4115
|
Published Date
July 2025
|
Pages
269
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Viral Vector Vaccines Market size was valued at US$ 850.43 Million in 2024, expanding at a CAGR of 15.93% from 2025 to 2032.
Viral vector vaccines utilize a harmless virus as a delivery vehicle to introduce genetic material from a pathogen into the body. This genetic material directs cells to produce a specific protein that stimulates an immune response without causing illness. By mimicking a natural infection, these vaccines train the immune system to recognize and combat the actual virus if encountered in the future. They have been widely employed in preventing infectious diseases such as COVID-19 and Ebola. Globally, governments have strongly supported the development and distribution of viral vector vaccines through substantial funding initiatives and public health campaigns. For instance, the U.S. government’s Operation Warp Speed invested billions to accelerate COVID-19 vaccine development, including viral vector platforms, while the World Health Organization continues to endorse these vaccines as key tools in combating pandemics worldwide.
Viral Vector Vaccines Market- Market Dynamics
Rising prevalence of infectious diseases is expected to drive market demand.
The rising incidence of infectious diseases such as COVID-19, influenza, and hepatitis is driving the demand for effective vaccines. According to the World Health Organization (WHO), vaccines prevent 2 to 3 million deaths annually, underscoring their vital role in global health. Advances in genetic engineering have further enabled the development of more efficient viral vector vaccines. However, although rare, reports of adverse effects have contributed to public hesitancy, which may hinder market growth in the coming years. Conversely, developing regions offer significant growth opportunities due to improving healthcare infrastructure and increasing awareness of vaccination benefits.
Viral Vector Vaccines Market- Segmentation Analysis:
The Global Viral Vector Vaccines Market is segmented on the basis of Disease, Type, End User, and Region.
The global viral vector vaccines market is segmented by disease into infectious diseases, cancer, genetic disorders, and others, with infectious diseases expected to hold the largest market share throughout the forecast period. This dominance is primarily due to the substantial global burden of infectious diseases and the proven efficacy of viral vector platforms in developing effective vaccines against these illnesses. According to the World Health Organization (WHO), infectious diseases continue to account for approximately 20% of global mortality, underscoring the urgent need for innovative vaccine solutions like viral vector vaccines to combat outbreaks and endemic infections worldwide.
When categorized by type, the market includes adeno-associated virus (AAV), adenovirus, lentivirus, retrovirus, and others, with the adenovirus segment anticipated to capture the largest market share during the forecast period. Adenoviruses are widely favored for their strong immunogenicity, capacity to carry large genetic payloads, and suitability for rapid vaccine development, making them a versatile tool in vaccine research and deployment. The U.S. National Institutes of Health (NIH) reports that adenovirus-based vaccines currently represent over 60% of viral vector vaccine candidates in clinical trials, reflecting their pivotal role in accelerating vaccine availability for urgent public health needs.
Geographically, North America holds the largest share of the global viral vector vaccines market, driven by its advanced healthcare infrastructure, significant investments in research and development, and the presence of major pharmaceutical and biotechnology companies. The U.S. government alone allocated over $12 billion in 2023 toward vaccine research and pandemic preparedness, highlighting the region’s leadership in advancing vaccine technologies. Meanwhile, the Asia-Pacific region is projected to experience the fastest market growth, propelled by increased healthcare spending, a rising incidence of infectious diseases, and growing public awareness of advanced therapeutic options. According to the Asian Development Bank, healthcare investments in the Asia-Pacific region have grown by 8% annually since 2020, positioning it as a rapidly expanding market for viral vector vaccines.
Viral Vector Vaccines Market- Geographical Insights
North America holds the largest share of the global viral vector vaccines market, driven by its advanced healthcare infrastructure, significant investments in research and development, and the presence of major pharmaceutical and biotechnology companies. The U.S. government alone allocated over $12 billion in 2023 toward vaccine research and pandemic preparedness, highlighting the region’s leadership in advancing vaccine technologies. Meanwhile, the Asia-Pacific region is projected to experience the fastest market growth, propelled by increased healthcare spending, a rising incidence of infectious diseases, and growing public awareness of advanced therapeutic options. According to the Asian Development Bank, healthcare investments in the Asia-Pacific region have grown by 8% annually since 2020, positioning it as a rapidly expanding market for viral vector vaccines.
Viral Vector Vaccines Market- Competitive Landscape:
The rising global demand for effective and rapid-response vaccines is driving technological innovation and strategic investments in the viral vector vaccine market. Companies are focusing on optimizing vector design, enhancing safety profiles, and expanding manufacturing capacities to keep pace with growing needs. Collaborations with research institutions and government agencies are increasingly common to accelerate development and streamline regulatory approvals. Additionally, industry players are diversifying their product pipelines to address emerging infectious diseases. Efforts to expand regional footprints through acquisitions and partnerships are also underway to improve global access to advanced vaccine platforms.
Recent Developments:
- In June 2025, ImmunoPrecise Antibodies Ltd. identified a stable epitope common to all four dengue virus serotypes using its AI-powered LENSai™ platform. This breakthrough advances the development of a universal dengue vaccine through epitope-based targeting.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL VIRAL VECTOR VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Advanced Bioscience Laboratories
- Sanofi S.A.
- C.H. Boehringer Sohn AG & Ko
- Brammer Bio, LLC
- GE Healthcare
- Creative Biogene
- Pfizer Inc.
- Moderna Inc.
- Sinovac Biotech Ltd.
- CSL Ltd.
- Astra Zeneca plc
- GSK plc
- Serum Institute of India Pvt. Ltd.
- Merck & Co. Inc.
- Novasep
- Charles River Laboratories
- Waisman Biomanufacturing
- uniQure N.V.
- Creative-Biogene
- Addgene
- Aldevron
- Thermo Fisher Scientific Inc.
- Spark Therapeutics Inc.
- Others
GLOBAL VIRAL VECTOR VACCINES MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032
- Infectious Diseases
- Cancer
- Genetic Disorders
- Others
GLOBAL VIRAL VECTOR VACCINES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Adeno-associated virus (AAV)
- Adenovirus
- Lentivirus
- Retrovirus
- Others
GLOBAL VIRAL VECTOR VACCINES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical and Biopharmaceutical Companies
- Research Institutes
GLOBAL VIRAL VECTOR VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Viral Vector Vaccines Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Viral Vector Vaccines Market Snippet by Disease
2.1.2. Viral Vector Vaccines Market Snippet by Type
2.1.3. Viral Vector Vaccines Market Snippet by End User
2.1.4. Viral Vector Vaccines Market Snippet by Country
2.1.5. Viral Vector Vaccines Market Snippet by Region
2.2. Competitive Insights
3. Viral Vector Vaccines Key Market Trends
3.1. Viral Vector Vaccines Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Viral Vector Vaccines Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Viral Vector Vaccines Market Opportunities
3.4. Viral Vector Vaccines Market Future Trends
4. Viral Vector Vaccines Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Viral Vector Vaccines Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Viral Vector Vaccines Market Landscape
6.1. Viral Vector Vaccines Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Viral Vector Vaccines Market – By Disease
7.1. Overview
7.1.1. Segment Share Analysis, By Disease, 2024 & 2032 (%)
7.1.2. Infectious Diseases
7.1.3. Cancer
7.1.4. Genetic Disorders
7.1.5. Others
8. Viral Vector Vaccines Market – By Type
8.1. Overview
8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
8.1.2. Adeno-associated virus (AAV)
8.1.3. Adenovirus
8.1.4. Lentivirus
8.1.5. Retrovirus
8.1.6. Others
9. Viral Vector Vaccines Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Pharmaceutical and Biopharmaceutical Companies
9.1.3. Research Institutes
10. Viral Vector Vaccines Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Viral Vector Vaccines Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Viral Vector Vaccines Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Viral Vector Vaccines Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Viral Vector Vaccines Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Viral Vector Vaccines Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Viral Vector Vaccines Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Advanced Bioscience Laboratories
11.2.2. Sanofi S.A.
11.2.3. C.H. Boehringer Sohn AG & Ko
11.2.4. Brammer Bio, LLC
11.2.5. GE Healthcare
11.2.6. Creative Biogene
11.2.7. Pfizer Inc.
11.2.8. Moderna Inc.
11.2.9. Sinovac Biotech Ltd.
11.2.10. CSL Ltd.
11.2.11. Astra Zeneca plc
11.2.12. GSK plc
11.2.13. Serum Institute of India Pvt. Ltd.
11.2.14. Merck & Co. Inc.
11.2.15. Novasep
11.2.16. Charles River Laboratories
11.2.17. Waisman Biomanufacturing
11.2.18. uniQure N.V.
11.2.19. Creative-Biogene
11.2.20. Addgene
11.2.21. Aldevron
11.2.22. Thermo Fisher Scientific Inc.
11.2.23. Spark Therapeutics Inc.
11.2.24. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
